# Study Evaluating rhBMP-2/CPM in Closed Distal Radius Fractures

> **NCT00161629** · PHASE1 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 40 (estimated)

## Conditions studied

- Radius Fractures

## Interventions

- **DRUG:** rhBMP-2/CPM

## Key facts

- **NCT ID:** NCT00161629
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2007-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00161629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00161629, "Study Evaluating rhBMP-2/CPM in Closed Distal Radius Fractures". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00161629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*